搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 5 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Prehistoric lake sturgeon is not endangered, US says despite calls from conservationists
Bastillepost· 6 日前Lake sturgeon don't need Endangered Species Act protections, federal wildlife officials ...